Table 1—

Evaluation of the DQIP measures in nine managed care plans with Medicare participation

MeasureMeanMaximumMinimum
HbA1c testing (annual)729350
HbA1c ≥9.5%355512
Lipid testing (biennial)627447
LDL <130 mg/dl384922
Blood pressure controlled (based on last value)374731
Foot examination (annual)426116
Eye examination (biennial for low-risk*, otherwise annual)41728
Nephropathy monitored346322
  • Data are %. Denominators for all measures were Medicare beneficiaries aged 18–75 years identified with diabetes using a validated algorithm based on ICD-9 codes or selected from pharmacy records based on use of insulin or oral agents for treating diabetes. Percentages shown reflect the proportion of patients receiving the test or achieving the result specified. All plans had ≥100 records.

  • *

    * Low-risk patients had two of the following: no retinopathy in the examination before the reporting year, not taking insulin, or an HbA1c level of ≤8%.

  • Low-risk patients had two of the following: no microalbuminuria on testing in the year before the reporting year, not taking insulin, or an HbA1c level of ≤8%.